文献速递临床生化临床免疫质量管理与危急值

基于LC-MS的参考测量程序与免疫分析法测定载脂蛋白A-I和B的相关性与互换性研究

Correlation and Commutability Study between an LC-MS-Based Reference Measurement Procedure and Immunoassays Measuring Apolipoprotein A-I and Apolipoprotein B.
PubMed 文献 · Clin Chem · 2026-01-01

IFCC载脂蛋白质谱工作组开发了基于质谱的多重参考测量程序(RMP),并与8种免疫分析法在30份临床样本中比较ApoA-I和ApoB的一致性,同时评估8种候选参考物质及WHO-IFCC标准品的互换性。结果显示RMP与免疫法相关性良好,但免疫法间协调性仍需改善;ApoB候选参考物质的互换性变异较大,SP3-08在多个方法比较中显示非互换性。

要点

  • RMP与免疫法测定ApoA-I和ApoB的相关性良好,选择性可比。
  • 8种免疫法间ApoA-I和ApoB的协调化水平仍需提高。
  • ApoB候选参考物质互换性变异较大,SP3-08在多个比较中非互换。

核心结论

  • RMP与免疫法对ApoA-I和ApoB具有可比的选择性,完善的参考测量体系可改善协调化。
  • 未来互换性二级参考物质可基于冷冻人血清池,但ApoB可能需要预选单供者样本以限制样本特异性效应。

研究设计与样本

  • IFCC载脂蛋白质谱工作组开发基于质谱的多重参考测量程序(RMP)及互换性二级参考物质。
  • 使用30份临床样本比较RMP与8种免疫分析法的结果一致性。
  • 评估8种候选参考物质(冷冻血清池)及WHO-IFCC标准品SP1-01和SP3-08的互换性。

主要发现

  • 8种免疫法测定ApoA-I和ApoB的协调化水平仍需改善。
  • RMP结果与免疫法结果在ApoA-I和ApoB上均显示良好相关性。
  • ApoA-I:7种候选参考物质互换性良好,SP1-01和一种候选参考物质在某一方法比较中显示潜在非互换性。
  • ApoB:候选参考物质互换性变异较大,SP3-08在多个方法比较中显示非互换性。

临床怎么用

  • 临床实验室应关注ApoA-I和ApoB免疫法间的协调化差异,推动参考测量体系应用。
  • 选择ApoB参考物质时需注意互换性变异,单供者样本预选可能减少样本特异性效应。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Serum concentrations of apolipoprotein A-I (ApoA-I) and apolipoprotein B (ApoB) can have a predictive value for cardiovascular events beyond the traditional lipid profile. The IFCC Working Group on Apolipoproteins by Mass Spectrometry is developing a novel reference measurement system for seven clinically relevant apolipoproteins, including ApoA-I and ApoB. The system will consist of a multiplex mass spectrometry-based reference measurement procedure (RMP) and commutable secondary reference materials (RMs). METHODS: Agreement between the RMP and 8 immunoassay-based measurement procedures (MPs) was investigated using 30 clinical samples. Furthermore, the commutability of 8 candidate RMs, consisting of frozen serum pools, and the existing WHO-IFCC standards SP1-01 and SP3-08 was assessed. RESULTS: The harmonization level among eight immunoassay-based MPs for ApoA-I and ApoB still needs improvement. The RMP results showed a good correlation with results of the immunoassay-based MPs for both ApoA-I and ApoB. For ApoA-I, 7 candidate RMs showed good commutability, while SP1-01 and one candidate RM showed potential noncommutability for one method comparison. For ApoB, the commutability profile of the candidate RMs was more variable, and SP3-08 showed noncommutability for several method comparisons. CONCLUSIONS: The RMP and the immunoassay-based MPs have comparable selectivity for ApoA-I and ApoB, and a well-established reference measurement system can lead to improved harmonization. Future commutable secondary RMs can be based on frozen human serum pools; however, for ApoB, preselection of single-donor samples might be needed to limit the impact of sample-specific effects.

来源:Clin Chem,查看原文。版权归原作者所有。

引用

  1. Dikaios I, Cobbaert CM, Delatour V, et al. Correlation and Commutability Study between an LC-MS-Based Reference Measurement Procedure and Immunoassays Measuring Apolipoprotein A-I and Apolipoprotein B. Clin Chem. 2026. PMID: 42303280. doi:10.1093/clinchem/hvag063

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。